We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Renovaro Inc | TG:2Q5 | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|
| 0.138 | 18.25% | 0.894 | 179 | 22:50:15 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.865 | 0.925 | 0.905 | 0.746 | 0.746 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 20:41:32 | 135 | 0.905 | EUR |
| Date | Time | Source | Headline |
|---|---|---|---|
| 30/12/2024 | 14:00 | UKREG | Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV |
| 23/12/2024 | 14:00 | UKREG | RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding.. |
| 20/12/2024 | 20:40 | UKREG | Renovaro Regains Compliance with NASDAQ Listing Requirement |
| 20/12/2024 | 14:00 | UKREG | Renovaro Enters into a Strategic Collaboration with Nebul to Advance a.. |
| 04/11/2024 | 13:31 | UKREG | Renovaro Issues Shareholder Letter and Provides Corporate Update |
| 17/10/2024 | 13:15 | UKREG | RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics.. |
| 16/10/2024 | 13:28 | UKREG | Renovaro Announces Strategic Restructuring and Leadership Transition |
| 19/9/2024 | 13:00 | UKREG | PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate.. |
| 17/9/2024 | 13:00 | UKREG | Independent Expert Assessment Validates RenovaroCube’s Potential as a.. |
| 13/9/2024 | 13:00 | UKREG | RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at.. |
Renovaro (2Q5) Share Charts1 Year Renovaro Chart |
|
1 Month Renovaro Chart |
Intraday Renovaro Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
